Latest Pulmo BioTech Stories
Pulmo BioTech has announced that its subsidiary, PulmoScience has completed the bio-distribution studies on its DFH-12 product candidate for the PulmoBind technology of molecular imaging of the vascular system of the lungs. The in- vivo studies have shown that the molecule is predominantly retained in the lungs 30 minutes after injection with only minor retention in the liver and heart. Further bio-distribution studies have also shown that after 240 minutes the majority of the injected...
- A punctuation mark (/) used to separate related items of information.
- A little rod; a twig.